This is an excellent update. Exceeded last months revenue...

This is an excellent update.

• Exceeded last months revenue guidance, projected ($58M-$61M), actual ($64M).
• All markets get a mention (US, AU, NZ and UK).
• Margins up.
• Cash on hand up.
• inMotion in 10,000 of 34,000 US pharmacies.
• Profitable in FY24.
• The March quarter will be telling:
  • $11M (last year) and back down the snake, $20M (hopeful) and we'll be using the ladder.

MedTech usually bucks the trend in recessions, so MedAdvisor in 2023 could be a safe bet.

I don't have a PhD in Typography but I wish they could maintain the same font between updates. I'm all for updating brand imaging, which occurred recently and annual reports to maybe amend format and layout, but looking across the announcement from 21/12 and this one they use bold highlights, some underlined titles, different font. My OCD brain finds it odd.